Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4)
Clinical trial NCT01399619 · COMPLETED
Trial details
- NCT number
- NCT01399619
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2013-09-01
- Enrollment
- 310
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.